Health Care

— Feb 5, 2019
Printer-friendly version
Health Care Reform Options for Alberta

Health Care Reform Options for Alberta finds that the Alberta government can enact major health-care reforms—without contravening the Canada Health Act—that would shorten wait times and improve patient care. For example, increasing the use of private clinics, creating a centralized surgical registry and pooling patient referrals, and allowing private, parallel financing and delivery of medically necessary services, none of which are explicitly prohibited by federal legislation.

— Jan 24, 2019
Printer-friendly version
Pharmaceutical Regulation, Innovation, and Access to New Drugs: An International Perspective

Pharmaceutical Regulation, Innovation, and Access to New Drugs: An International Perspective finds that the federal government’s plan to lower prescription drug prices through changes to the Patented Medicine Prices Review Board could impede access of new life-saving drugs for Canadian patients and even discourage innovation in the pharmaceutical sector.

— Dec 13, 2018
Printer-friendly version
The Unintended Consequences of National Pharmacare Programs: The Experiences of Australia, New Zealand, and the UK

The Unintended Consequences of National Pharmacare Programs in Australia, New Zealand and the UK finds that publicly-funded pharmacare schemes—similar to what some policymakers in Canada are considering—in other developed countries have resulted in reduced access to new drugs for patients, drug shortages, higher taxes and less pharmaceutical innovation.

— Dec 4, 2018
Printer-friendly version
Waiting Your Turn: Wait Times for Health Care in Canada, 2018 Report

Waiting Your Turn: Wait Times for Health Care in Canada, 2018 finds that the median wait time for medically necessary treatment in Canada this year was 19.8 weeks. Among the provinces, Saskatchewan has the shortest median wait time this year at 15.4 weeks, and New Brunswick again recorded the longest wait time (45.1 weeks).

— Nov 8, 2018
Printer-friendly version

Comparing Performance of Universal Health Care Countries, 2018 finds that Canada spends more on health care than a majority of 28 comparable countries with universal coverage, but ranks near the bottom in terms of the number of physicians and hospital beds, and Canada suffers from the longest wait times.

— Oct 16, 2018
Printer-friendly version
Provincial Drug Coverage for Vulnerable Canadians

Provincial Drug Coverage for Vulnerable Canadians finds that every province already provides prescription drug coverage to help Canadians—particularly seniors and lower-income Canadians—pay for pharmaceuticals. Crucially, provinces are able to establish prescription drug plans to suit their particular priorities, population age, income levels and other factors, which differ from province to province. This customization would likely be lost or at least diluted if Canada adopts a national pharmacare program.

— Aug 28, 2018
Printer-friendly version
Regulatory, Reimbursement, and Pricing Barriers to Accessing Drugs for Rare Disorders in Canada

Regulatory, Reimbursement and Pricing Barriers to Accessing Drugs for Rare Disorders in Canada finds that the federal government’s plan to increasingly regulate the costs of pharmaceuticals could mean Canadians suffering from cystic fibrosis and other rare diseases may soon lose access to new innovative drug treatments, even though these patients are already denied new drugs available elsewhere.

Research Experts